Critical Assessment of Side Chain Conformation Prediction in Modelling of Single Point Amino Acid Mutation

Conference paper
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 680)


We assessed the ability of three widely used and freely available programs for side chain repacking to simulate the structural effects of single point mutations. The programs tested seem to produce sufficiently reliable predictions only when mutations involve residues characterized by limited flexibility. The change in size and/or polarity of the mutant side chain can affect the performances of the different programs. The correlation between the quality of predictions, exposure to solvent, and B-factors of the corresponding residues in crystal is also investigated. This analysis may provide non-experts with insights into what types of modelling protocols work best for such a problem as well as providing information to developers for improving their algorithms.


Amino acid Conformation prediction Mutation Protein structure Quality of predictions 



A preliminary version of this work was presented at the Annual Meeting of the Bioinformatics Italian Society (BITS), Naples, 26-28/4/2007. This work was partially supported by “Italia-USA Farmacogenomica Oncologica” Conv. no. 527/A/3A/5 and “Progetto CNR-Bioinformatics.”


  1. 1.
    Antonarakis SE, Krawczak M, Cooper DN (2008) The nature and mechanisms of human gene mutation. In Valle D et al (eds) The online metabolic and molecular bases of inherited disease, McGraw-Hill, Columbus, USAGoogle Scholar
  2. 2.
    Berman H, Henrick K, Nakamura H et al (2007) The worldwide Protein Data Bank (wwPDB): ensuring a single, uniform archive of PDB data. Nucleic Acids Res 35:D301–D303PubMedCrossRefGoogle Scholar
  3. 3.
    Canutescu A, Shelenkov AA, Dunbrack RL (2003) A graph-theory algorithm for rapid protein side-chain prediction. Protein Sci 12:2001–2014PubMedCrossRefGoogle Scholar
  4. 4.
    el-Bastawissy E, Knaggs MH, Gilbert IH (2001) Molecular dynamics simulations of wild-type and point mutation human prion protein at normal and elevated temperature. J Mol Graph Model 20:145–154PubMedCrossRefGoogle Scholar
  5. 5.
    Falconi M, Biocca S, Novelli G et al (2007) Molecular dynamics simulation of human LOX-1 provides an explanation for the lack of OxLDL binding to the Trp150Ala mutant. BMC Struct Biol 7:73PubMedCrossRefGoogle Scholar
  6. 6.
    Feyfant E, Sali A, Fiser A (2007) Modeling mutations in protein structures. Protein Sci 16:2030–2041PubMedCrossRefGoogle Scholar
  7. 7.
    Hubbard SJ, Campbell SF, Thornton JM (1991) Molecular recognition. Conformational analysis of limited proteolytic sites and serine proteinase protein inhibitors. J Mol Biol 220:507–530PubMedCrossRefGoogle Scholar
  8. 8.
    Li IT, Pham E, Truong K (2007) Current approaches for engineering proteins with diverse biological properties. Adv Exp Med Biol 620:18–33PubMedCrossRefGoogle Scholar
  9. 9.
    Liu B, Bernard B, Wu JH (2006) Impact of EGFR point mutations on the sensitivity to gefitinib: insights from comparative structural analyses and molecular dynamics simulations. Proteins 65:331–346PubMedCrossRefGoogle Scholar
  10. 10.
    Marabotti A (2008) Modeling the conformation of side chains in proteins: approaches, problems and possible developments. Curr Chem Biol 2:200–214Google Scholar
  11. 11.
    Matsumura M, Wozniak JA, Sun DP et al (1989) Structural studies of mutants of T4 lysozyme that alter hydrophobic stabilization. J Biol Chem 264:16059–16066PubMedGoogle Scholar
  12. 12.
    McLachlan AD (1982) Rapid comparison of protein structures. Acta Crystallogr A 38:871–873CrossRefGoogle Scholar
  13. 13.
    Nicholson H, Anderson DE, Dao-pin S et al (1991) Analysis of the interaction between charged side chains and the alpha-helix dipole using designed thermostable mutants of phage T4 lysozyme. Biochemistry 30:9816–9828PubMedCrossRefGoogle Scholar
  14. 14.
    Novotny J, Bruccoleri R, Karplus M (1984) An analysis of incorrectly folded protein models. Implications for structure predictions. J Mol Biol 177:787–818PubMedCrossRefGoogle Scholar
  15. 15.
    Novotny M, Seibert M, Kleywegt GJ (2007) On the precision of calculated solvent-accessible surface areas. Acta Crystallogr D Biol Crystallogr 63:270–274PubMedCrossRefGoogle Scholar
  16. 16.
    Peterson RW, Dutton PL, Wand AJ (2004) Improved side-chain prediction accuracy using an ab initio potential energy function and a very large rotamer library. Protein Sci 13:735–751PubMedCrossRefGoogle Scholar
  17. 17.
    Rost B, Sander C (1993) Prediction of protein secondary structure at better than 70% accuracy. J Mol Biol 232:584–599PubMedCrossRefGoogle Scholar
  18. 18.
    Sali A, Blundell TL (1993) Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 234:779–815PubMedCrossRefGoogle Scholar
  19. 19.
    Shih HHL, Brady J, Karplus M (1985) Structure of proteins with single-site mutations: a minimum perturbation approach. Proc Natl Acad Sci USA 82:1697–1700PubMedCrossRefGoogle Scholar
  20. 20.
    Snow ME, Amzel LM (1986) Calculating three-dimensional changes in protein structure due to amino-acid substitutions: the variable region of immunoglobulins. Proteins 1:267–279PubMedCrossRefGoogle Scholar
  21. 21.
    Summers NL, Carlson WD, Karplus M (1987) Analysis of side-chain orientations in homologous proteins. J Mol Biol 196:175–198PubMedCrossRefGoogle Scholar
  22. 22.
    Xiang Z (2006) Advances in homology protein structure modeling. Curr Protein Pept Sci 7:217–227PubMedCrossRefGoogle Scholar
  23. 23.
    Xiang Z, Honig B (2001) Extending the accuracy limits of prediction for side-chain conformations. J Mol Biol 311:421–430PubMedCrossRefGoogle Scholar
  24. 24.
    Yuan Z, Bailey TL, Teasdale RD (2005) Prediction of protein B-factor profiles. Proteins 58:905–912PubMedCrossRefGoogle Scholar
  25. 25.
    Zamyatin AA (1972) Protein volume in solution. Prog Biophys Mol Biol 24:107–123CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Institute of Biomedical TechnologiesNational Research CouncilSegrateItaly

Personalised recommendations